Current Concepts in the Treatment of Congestive Heart Failure

Cardiology (Switzerland)

Volumn 88, Issue , 1997, Pages 2-6

  Cohn, Jay N ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

ACE inhibitors; Heart failure; Hydralazine; Isosorbide dinitrate; Left ventricular dysfunction; Mortality; Quality of life

Indexed keywords

CAPTOPRIL; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FLOSEQUINAN; HYDRALAZINE; INOTROPIC AGENT; ISOSORBIDE DINITRATE; MILRINONE; PIMOBENDAN; RAMIPRIL; VASODILATOR AGENT;

ARTICLE; CONGESTIVE HEART FAILURE; EXERCISE TOLERANCE; HEART HEMODYNAMICS; LIFE EXPECTANCY; MORBIDITY; MORTALITY; PRIORITY JOURNAL; QUALITY OF LIFE; SIDE EFFECT; SYMPTOM;

HEART FAILURE, CONGESTIVE; HUMANS; QUALITY OF LIFE; SURVIVAL RATE;

EID: 0030974855     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000177477     Document Type: Article

References (29)

1. Cohn JN: Current therapy of the failing heart. Circulation 1988:78:1099-1107.
2. Cohn JN. Johnson GR. Shabetai R. Loeb H. Tristani F. Rector T. Smith R. Fletcher R. for the V-HeFT VA Cooperative Studies Group: Ejection fraction, peak exercise oxygen consumption. cardiothoracic ratio, ventricular arrhythmias and plasma norepinephrine as determinants of prognosis in heart failure. Circulation 1993:87: VI-5-VI-16.
3. Goldman S. Johnson G. Cohn JN. Cintron G, Smith R. Francis G. for the V-HcFT VA Cooperative Studies Group: Mechanism of death in heart failure: the Vasodilator-Heart Failure Trials. Circulation 1993:87:VI-24-VI-31.
4. Packer M. Carver JR. Rodcheffer RJ. Ivanhoe R.I. DiBianco R. Zcldis SM. Hendrix GH. Bommer W.I, Elkayam U. Kukin ML, Mallis GI. Sollano JA. Shannon J. Tandon PK. De-Mets DI. for the PROMISE Study Research Group: Effect of oral milrinone on mortality in severe chronic heart failure. N Engl J Med 1991:325:1468-1475.
5. Packer M. Rouleau J. Swedberg K. Pitt B. Fisher L. Klepper M. and the PROFILE Investigators: Effect of flosequinan on survival in chronic heart failure: preliminary results of the PROFILE study. Circulation 1993:88:1-301 (abstract).
6. Waagstein F. Hjalmarson A. Varnauskas E, Wallentin I: Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 1975:137:1022-1036.
7. Cohn JN. Johnson G. Zieschc S. Cobb F. Francis G. Tristani F. Smith R. Dunkntan WB. Loeb H. Wong M. Bhat G. Goldman S, Fletcher RD. Doherty J. Hughes CV. Carson P. Cintron G. Shabetai R. Haakcnson C: A comparison of cnalapril with hydralazine-isosorbidc dinitrate in the treatment of chronic congestive heart failure. N Engl J Med 1991:325:303-310.
8. Rector TS. Kubo SK. Cohn JN: Patients' self-assessment of their congestive heart failure. Part 2. Content, reliability and validity of a new measure. The Minnesota Living with Heart Failure Questionnaire. Heart Failure 1987:3:198-209.
9. Uretsky BF, Young JB. Shakide FG, Yellow LG, Harrison MC. Jolly MK: Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. J Am Coll Cardiol 1993:22:955-962.
10. DiBianco R. Shabetai R. Kostuk W. Moran J. Sehlant RC. Wright R: A comparison of oral milrinone, digoxin and their combination in the treatment of patients with chronic heart failure. N Engl J Med 1989:320:677-683.
11. Kubo SH. Gollub S. Bourgc R. Rahko P. Cobb F. Jessup M. Brozena S. Brodsky M. Kirlin P. Shanes J. Konstam M. Gradman A. Morledge J. Cinquegrani M. Singh S. LeJemtel T. Nicklas J. Troha J. Cohn JN. for the Pimobendan Multicenter Research Group: Beneficial effects of pimobendan on exercise tolerance and quality of life in patients with heart failure: results of a multicentcr trial. Circulation 1992:83:942-949.
12. The Digitalis Investigation Group: Rationale, design, implementation, and baseline characteristics of patients in the DIG trial: a large, simple, long-term trial to evaluate the effect of digitalis on mortality in heart failure. Controlled Clin Trials 1996:17:77-97.
13. Cohn JN. Archibald DG. Ziesche S. Franciosa JA. Harston WE. Tristani FE, Dunkman WB. Jacobs W. Francis GS, Flohr KH. Goldman S, Cobb FR. Shah PM. Saunders R. Fletcher RD, Loeb HS. Hughes VC. Baker B: Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study (V-HeFT). N Engl J Med 1986:314:1547-1552.
14. The CONSENSUS Trial Study Group: EITccts of enalapril on mortality in severe congestive heart failure. N Engl J Mcd 1987:316:1429-1435.
15. Smith RF, Johnson G, Ziesche S, Bhal G, Blankenship K. Cohn JN. for the V-HeFT VA Cooperative Studies Group: Functional capacity in heart failure: comparison of methods for assessment and their relation to other indexes of heart failure. Circulation 1993;87:VI-88-VI-93.
16. Rector TS. Francis GS. Cohn JN: Patients’self-assessment of their congestive heart failure. Part I. Patient-perceived dysfunction and its poor correlation with maximal exercise tests. Heart Failure 1987;3:192-196.
17. Massie BM. Berk MR. Brozena S. Elkayam U, Plehn J. Kukin M, Murphy B. Neuberg G, Steingarl R. DeHaan H for the FACET Investigators: Can further benefit be achieved by adding a vasodilator to triple therapy in CHF: results of the flosequinan-ACE inhibitor trial (FACET)? Circulation 1992;86:1-645 (abstract).
18. Rector TS. Kubo SH. Cohn JN: Validity of the Minnesota Living with Heart Failure Questionnaire as a measure of therapeutic response: effects of enalapril and placebo. Am J Cardiol 1993;71:1106-1107.
19. The SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 1991:325:293-302.
20. Picrpont GL. Cohn JN. Franciosa JA: Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside. Chest 1978:73:8-13.
21. Ziesche S, Cobb FR. Cohn JN. Johnson G. Tristani F for the V-HeFT VA Cooperative Studies Group: Hydralazine and isosorbide dinitrate combination improves exercise tolerance in heart failure: results from V-HeFT 1 and V-HeFT II. Circulation 1993:87:VI-56-VI-64.
22. Packer M. Gheorghiadc M. Young JB, Con-stantini PJ. Adams KF. Cody RJ. Smith LK. Van Voorhecs L. Gourlcy LA. Jolly MK, for the RADIANCE Study: Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting enzyme inhibitors. N Engl J Med 1993:329:1-7.
23. Cohn JN: The Vasodilator-Heart Failure Trials (V-HcFT): Introduction. Circulation 1993:87: VI-1-VI-4.
24. Pfcffer MA. Braunwald E, Moyé LA. Basta L. Brown EJ, Cuddy TE. Davis BR. Geltman EM. Goldman S. Flaker GC, Klein M. Lamas GA. Packer M, Rouleau J, Rouleau JL. Rutherford J. Wertheimer JH. Hawkins CM. on Behalf of the SAVE Investigators: The effect of captopril on mortality and morbidity in patients with left ventricular dysfunction following myocardial infarction: results of the survival and ventricular enlargement (SAVE) trial. N Engl J Med 1992:327:669-677.
25. The Acute infarction Ramipril Efficacy (AIRE) Study Investigators: Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993;342:821-828.
26. McDonald KM. Garr M, Carlyle PF. Francis GS, Hauer K, Hunter DW. Parish T. Stillman A, Cohn JN: Relative effects of alpha 1 adrenoceptor blockade, converting enzyme inhibitor therapy, and angiotensin II subtype I receptor blockade on ventricular remodeling in the dog. Circulation 1994:90:3034-3046.
27. McDonald KM, Francis GS, Matthews JH. Hunter D, Cohn JN: Long-term oral nitrate therapy prevents chronic ventricular remodeling in the dog. J Am Coll Cardiol 1993:21:514-522.
28. Francis GS. Cohn JN. Johnson G. Rector TS. Goldman S. Simon A. for the V-HeFT VA Cooperative Studies Group: Plasma norepinephrine. plasma renin activity, and congestive heart failure: relations to survival and the effects of therapy in V-HeFT II. Circulation 1993;87:VI40-VI48.
29. Fletcher RD, Cintron GB. Johnson G. Omdorff J. Carson P. Cohn JN. for the V-HeFT VA Cooperative Studies Group: Enalapril decreases prevalence of ventricular tachycardia in patients with chronic congestive heart failure. Circulation 1993:87:VI-49-VI-55.